Published in Virology on August 15, 2004
Human coronavirus NL63 employs the severe acute respiratory syndrome coronavirus receptor for cellular entry. Proc Natl Acad Sci U S A (2005) 2.21
Potent cross-reactive neutralization of SARS coronavirus isolates by human monoclonal antibodies. Proc Natl Acad Sci U S A (2007) 1.76
Longitudinally profiling neutralizing antibody response to SARS coronavirus with pseudotypes. Emerg Infect Dis (2005) 1.36
Synthetic reconstruction of zoonotic and early human severe acute respiratory syndrome coronavirus isolates that produce fatal disease in aged mice. J Virol (2007) 1.32
Mucosal immunization with surface-displayed severe acute respiratory syndrome coronavirus spike protein on Lactobacillus casei induces neutralizing antibodies in mice. J Virol (2006) 1.12
Neutralizing antibody response and SARS severity. Emerg Infect Dis (2005) 1.08
Specific asparagine-linked glycosylation sites are critical for DC-SIGN- and L-SIGN-mediated severe acute respiratory syndrome coronavirus entry. J Virol (2007) 1.06
SARS molecular epidemiology: a Chinese fairy tale of controlling an emerging zoonotic disease in the genomics era. Philos Trans R Soc Lond B Biol Sci (2007) 1.03
Potent human monoclonal antibodies against SARS CoV, Nipah and Hendra viruses. Expert Opin Biol Ther (2009) 0.98
Development of a poliovirus neutralization test with poliovirus pseudovirus for measurement of neutralizing antibody titer in human serum. Clin Vaccine Immunol (2011) 0.97
Novel microneutralization assay for HCMV using automated data collection and analysis. J Immunol Methods (2007) 0.96
False-positive results in a recombinant severe acute respiratory syndrome-associated coronavirus (SARS-CoV) nucleocapsid-based western blot assay were rectified by the use of two subunits (S1 and S2) of spike for detection of antibody to SARS-CoV. Clin Vaccine Immunol (2006) 0.88
Differential sensitivities of severe acute respiratory syndrome (SARS) coronavirus spike polypeptide enzyme-linked immunosorbent assay (ELISA) and SARS coronavirus nucleocapsid protein ELISA for serodiagnosis of SARS coronavirus pneumonia. J Clin Microbiol (2005) 0.87
A functional henipavirus envelope glycoprotein pseudotyped lentivirus assay system. Virol J (2010) 0.86
Development of an enzyme-linked immunosorbent assay-based test with a cocktail of nucleocapsid and spike proteins for detection of severe acute respiratory syndrome-associated coronavirus-specific antibody. Clin Vaccine Immunol (2008) 0.81
The DE and FG loops of the HPV major capsid protein contribute to the epitopes of vaccine-induced cross-neutralising antibodies. Sci Rep (2016) 0.77
A combined nucleocapsid vaccine induces vigorous SARS-CD8+ T-cell immune responses. Genet Vaccines Ther (2005) 0.76
Protocol for recombinant RBD-based SARS vaccines: protein preparation, animal vaccination and neutralization detection. J Vis Exp (2011) 0.76
Viral glycoproteins: biological role and application in diagnosis. Virusdisease (2016) 0.75
Characterization and complete genome sequence of a novel coronavirus, coronavirus HKU1, from patients with pneumonia. J Virol (2005) 9.13
Unique and conserved features of genome and proteome of SARS-coronavirus, an early split-off from the coronavirus group 2 lineage. J Mol Biol (2003) 9.09
Heterosubtypic neutralizing monoclonal antibodies cross-protective against H5N1 and H1N1 recovered from human IgM+ memory B cells. PLoS One (2008) 6.98
A highly conserved neutralizing epitope on group 2 influenza A viruses. Science (2011) 5.66
Three Indonesian clusters of H5N1 virus infection in 2005. N Engl J Med (2006) 5.14
Lung pathology of fatal severe acute respiratory syndrome. Lancet (2003) 5.02
Middle East respiratory syndrome coronavirus (MERS-CoV): announcement of the Coronavirus Study Group. J Virol (2013) 4.98
Dating the emergence of pandemic influenza viruses. Proc Natl Acad Sci U S A (2009) 4.36
Emergence of a novel swine-origin influenza A virus (S-OIV) H1N1 virus in humans. J Clin Virol (2009) 4.10
MERS coronaviruses in dromedary camels, Egypt. Emerg Infect Dis (2014) 3.64
The genesis and source of the H7N9 influenza viruses causing human infections in China. Nature (2013) 3.60
Highly conserved protective epitopes on influenza B viruses. Science (2012) 3.47
Homozygous L-SIGN (CLEC4M) plays a protective role in SARS coronavirus infection. Nat Genet (2005) 2.82
MERS coronavirus in dromedary camel herd, Saudi Arabia. Emerg Infect Dis (2014) 2.47
Long-term evolution and transmission dynamics of swine influenza A virus. Nature (2011) 2.39
Hemagglutinin-neuraminidase balance confers respiratory-droplet transmissibility of the pandemic H1N1 influenza virus in ferrets. Proc Natl Acad Sci U S A (2011) 2.04
Cytokine responses in severe acute respiratory syndrome coronavirus-infected macrophages in vitro: possible relevance to pathogenesis. J Virol (2005) 1.76
Avian coronavirus in wild aquatic birds. J Virol (2011) 1.73
Tropism of and innate immune responses to the novel human betacoronavirus lineage C virus in human ex vivo respiratory organ cultures. J Virol (2013) 1.68
Tropism and innate host responses of the 2009 pandemic H1N1 influenza virus in ex vivo and in vitro cultures of human conjunctiva and respiratory tract. Am J Pathol (2010) 1.67
Induction of proinflammatory cytokines in primary human macrophages by influenza A virus (H5N1) is selectively regulated by IFN regulatory factor 3 and p38 MAPK. J Immunol (2009) 1.66
The nsp9 replicase protein of SARS-coronavirus, structure and functional insights. Structure (2004) 1.55
Detection of diverse astroviruses from bats in China. J Gen Virol (2009) 1.46
Hyperinduction of cyclooxygenase-2-mediated proinflammatory cascade: a mechanism for the pathogenesis of avian influenza H5N1 infection. J Infect Dis (2008) 1.46
Human monoclonal antibody combination against SARS coronavirus: synergy and coverage of escape mutants. PLoS Med (2006) 1.34
Mass extinctions, biodiversity and mitochondrial function: are bats 'special' as reservoirs for emerging viruses? Curr Opin Virol (2011) 1.33
Time course and cellular localization of SARS-CoV nucleoprotein and RNA in lungs from fatal cases of SARS. PLoS Med (2006) 1.31
Mutation of CpGs in the murine stem cell virus retroviral vector long terminal repeat represses silencing in embryonic stem cells. J Biol Chem (2003) 1.29
Codon usage bias and the evolution of influenza A viruses. Codon Usage Biases of Influenza Virus. BMC Evol Biol (2010) 1.28
Influenza A virus expresses high levels of an unusual class of small viral leader RNAs in infected cells. MBio (2010) 1.27
Characterization of a novel gyrovirus in human stool and chicken meat. J Clin Virol (2012) 1.26
Immunogenicity and ability of variable loop-deleted human immunodeficiency virus type 1 envelope glycoproteins to elicit neutralizing antibodies. Virology (2003) 1.24
Full factorial analysis of mammalian and avian influenza polymerase subunits suggests a role of an efficient polymerase for virus adaptation. PLoS One (2009) 1.22
Reliable universal RT-PCR assays for studying influenza polymerase subunit gene sequences from all 16 haemagglutinin subtypes. J Virol Methods (2007) 1.20
Absence of MERS-Coronavirus in Bactrian Camels, Southern Mongolia, November 2014. Emerg Infect Dis (2015) 1.17
Detection of novel astroviruses in urban brown rats and previously known astroviruses in humans. J Gen Virol (2010) 1.17
Human immunodeficiency virus type 1 envelope gp120 induces a stop signal and virological synapse formation in noninfected CD4+ T cells. J Virol (2008) 1.16
Intraspecies diversity of SARS-like coronaviruses in Rhinolophus sinicus and its implications for the origin of SARS coronaviruses in humans. J Gen Virol (2009) 1.16
Human immunodeficiency virus type 1 envelope gp120-induced partial T-cell receptor signaling creates an F-actin-depleted zone in the virological synapse. J Virol (2009) 1.14
Comparison of the NucliSens easyMAG and Qiagen BioRobot 9604 nucleic acid extraction systems for detection of RNA and DNA respiratory viruses in nasopharyngeal aspirate samples. J Clin Microbiol (2008) 1.13
Mucosal immunization with surface-displayed severe acute respiratory syndrome coronavirus spike protein on Lactobacillus casei induces neutralizing antibodies in mice. J Virol (2006) 1.12
The viruses of wild pigeon droppings. PLoS One (2013) 1.12
A case for the ancient origin of coronaviruses. J Virol (2013) 1.12
Initial viral load and the outcomes of SARS. CMAJ (2004) 1.11
Emergence and dissemination of a swine H3N2 reassortant influenza virus with 2009 pandemic H1N1 genes in pigs in China. J Virol (2011) 1.09
Biology of influenza a virus. Ann N Y Acad Sci (2007) 1.07
Assessment of antibody responses against gp41 in HIV-1-infected patients using soluble gp41 fusion proteins and peptides derived from M group consensus envelope. Virology (2007) 1.07
Specific asparagine-linked glycosylation sites are critical for DC-SIGN- and L-SIGN-mediated severe acute respiratory syndrome coronavirus entry. J Virol (2007) 1.06
Potent inhibition of SARS-associated coronavirus (SCOV) infection and replication by type I interferons (IFN-alpha/beta) but not by type II interferon (IFN-gamma). J Interferon Cytokine Res (2004) 1.05
Loop-mediated isothermal amplification for influenza A (H5N1) virus. Emerg Infect Dis (2007) 1.04
Differentiation of Hdm2-mediated p53 ubiquitination and Hdm2 autoubiquitination activity by small molecular weight inhibitors. Proc Natl Acad Sci U S A (2002) 1.03
Detection of highly pathogenic influenza and pandemic influenza virus in formalin fixed tissues by immunohistochemical methods. J Virol Methods (2011) 1.03
Lack of middle East respiratory syndrome coronavirus transmission from infected camels. Emerg Infect Dis (2015) 1.01
Serial analysis of the plasma concentration of SARS coronavirus RNA in pediatric patients with severe acute respiratory syndrome. Clin Chem (2003) 0.99
The severe acute respiratory syndrome (SARS) coronavirus NTPase/helicase belongs to a distinct class of 5' to 3' viral helicases. J Biol Chem (2003) 0.98
Middle East respiratory syndrome coronavirus (MERS-CoV) in dromedary camels in Nigeria, 2015. Euro Surveill (2015) 0.97
A novel small-molecule inhibitor of the avian influenza H5N1 virus determined through computational screening against the neuraminidase. J Med Chem (2009) 0.97
How can vaccines against influenza and other viral diseases be made more effective? PLoS Biol (2010) 0.96
Structural characterization of HIV gp41 with the membrane-proximal external region. J Biol Chem (2010) 0.95
Tissue tropism of swine influenza viruses and reassortants in ex vivo cultures of the human respiratory tract and conjunctiva. J Virol (2011) 0.93
HIV envelope gp120 activates LFA-1 on CD4 T-lymphocytes and increases cell susceptibility to LFA-1-targeting leukotoxin (LtxA). PLoS One (2011) 0.92
A novel group of avian astroviruses in wild aquatic birds. J Virol (2012) 0.90
Viral reassortment as an information exchange between viral segments. Proc Natl Acad Sci U S A (2012) 0.90
SARS coronavirus 8b reduces viral replication by down-regulating E via an ubiquitin-independent proteasome pathway. Microbes Infect (2010) 0.90
Entry of influenza A Virus with a α2,6-linked sialic acid binding preference requires host fibronectin. J Virol (2012) 0.89
Rapid genotyping of swine influenza viruses. Emerg Infect Dis (2011) 0.89
Swine influenza in Sri Lanka. Emerg Infect Dis (2013) 0.89
Prostaglandin E2 induces CYP1B1 expression via ligand-independent activation of the ERalpha pathway in human breast cancer cells. Toxicol Sci (2010) 0.88
Inhibition of SARS-associated coronavirus infection and replication by RNA interference. JAMA (2003) 0.88
Serum markers for necroinflammatory activity in patients with chronic viral hepatitis and normal or mildly elevated aminotransferase levels. Liver Int (2011) 0.88
The evolving threat of influenza viruses of animal origin and the challenges in developing appropriate diagnostics. Clin Chem (2012) 0.88
Genogroup I and II picobirnaviruses in respiratory tracts of pigs. Emerg Infect Dis (2011) 0.87
Molecular detection of human H7N9 influenza A virus causing outbreaks in China. Clin Chem (2013) 0.87
Evaluation of novel H1N1-specific primer-probe sets using commercial RT-PCR mixtures and a premixed reaction stored in a lyophilized format. J Virol Methods (2010) 0.86
Heterologous influenza vRNA segments with identical non-coding sequences stimulate viral RNA replication in trans. Virol J (2008) 0.85
Identification of critical determinants on ACE2 for SARS-CoV entry and development of a potent entry inhibitor. Virology (2006) 0.85
IL-15 adjuvanted multivalent vaccinia-based universal influenza vaccine requires CD4+ T cells for heterosubtypic protection. Proc Natl Acad Sci U S A (2014) 0.85
Structural analysis of a highly glycosylated and unliganded gp120-based antigen using mass spectrometry. Biochemistry (2010) 0.84
Asymptomatic MERS-CoV Infection in Humans Possibly Linked to Infected Dromedaries Imported from Oman to United Arab Emirates, May 2015. Emerg Infect Dis (2015) 0.84
Full sequence of HIV type 1 Korean subtype B in an AIDS case with atypical seroconversion: TAAAA at TATA box. AIDS Res Hum Retroviruses (2005) 0.83
Natural polymorphisms of protease in protease inhibitor-naive HIV-1 infected patients in Korea: a novel L63M in subtype B. AIDS Res Hum Retroviruses (2003) 0.83
BPR2-D2 targeting viral ribonucleoprotein complex-associated function inhibits oseltamivir-resistant influenza viruses. J Antimicrob Chemother (2010) 0.83
TEE-guided one-stage excision of intravenous leiomyomatosis with cardiac extension through an abdominal approach. J Cardiothorac Vasc Anesth (2005) 0.82
Scalarane sesterterpenoids: semisynthesis and biological activity. J Nat Prod (2009) 0.81
The emergence of human coronavirus EMC: how scared should we be? MBio (2013) 0.80
Antidepressant efficacy screening of novel targets in the chick anxiety-depression model. Behav Pharmacol (2009) 0.79
Transgenic plant-derived siRNAs can suppress propagation of influenza virus in mammalian cells. FEBS Lett (2004) 0.79
A statistical strategy to identify recombinant viral ribonucleoprotein of avian, human, and swine influenza A viruses with elevated polymerase activity. Influenza Other Respir Viruses (2013) 0.79
The ins and outs of fetal DNA in maternal plasma. Lancet (2003) 0.78
Transmissibility of pandemic H1N1 and genetically related swine influenza viruses in ferrets. Influenza Other Respir Viruses (2011) 0.76
Polyanhydride Nanovaccines Induce Germinal Center B Cell Formation and Sustained Serum Antibody Responses. J Biomed Nanotechnol (2016) 0.76
Detection of SARS coronavirus in humans and animals by conventional and quantitative (real time) reverse transcription polymerase chain reactions. Methods Mol Biol (2008) 0.76
Molecular epidemiology of influenza A(H1N1)pdm09 virus among humans and swine, Sri Lanka. Emerg Infect Dis (2014) 0.76
MERS-CoV Antibody Responses 1 Year after Symptom Onset, South Korea, 2015. Emerg Infect Dis (2017) 0.76
Use of fractional factorial design to study the compatibility of viral ribonucleoprotein gene segments of human H7N9 virus and circulating human influenza subtypes. Influenza Other Respir Viruses (2014) 0.75
DNA intercalator stimulates influenza transcription and virus replication. Virol J (2011) 0.75
A novel molecular test for influenza B virus detection and lineage differentiation. J Med Virol (2014) 0.75